¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2023 (2ÀÏÂ÷) : 2023-04-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2023 (2ÀÏÂ÷) : 2023-04-28
±³À°ÀÏÀÚ : 2023-04-28
±³À°Àå¼Ò : ¼­¿ï, ÄÚ¿¢½º

±³À°ÁÖÁ¦ : KSN(Korea Society of Nephrology) 2023 (2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3452-7265  

À̸ÞÀÏ : ksn@ksn.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 31 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 150,000¿ø  

ºñ°í ¡áȸ¿ø: »çÀü(100,000)/ÇöÀå(150,000) ¡áºñȸ¿ø: »çÀü(150,000)/ ÇöÀå(200,000) ¡áFellow,Resident,Trainee,Student,Nurse,etc: »çÀü(50,000)/ ÇöÀå(35,000) *Medical Student: ¸éÁ¦

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 28ÀÏ Auditorium 13:30~14:20 Cardiorenal Benefits of Finerenone: A New Distinctive Approach for Patient with DKD John Maesaka(NYU Long Island School of Medicine)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 08:30~09:00 Cerebral/Renal Salt Wasting: Typical Cases and Pathophysiology ±è¼öÇö(Áß¾Ó´ëÇб³ ±¤¸íº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 09:00~09:30 Urate Homeostasis and Risk of Hyperuricemia in Kidney Disease ÀÌÁ¤È¯(¼­¿ïƯº°½Ã º¸¶ó¸Åº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 09:30~10:00 Common Cases Referred to Nephrologists for Magnesium Disturbance ¹é¼±ÇÏ(ÇѸ²´ëÇб³ µ¿Åº¼º½Éº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 10:00~10:30 Common Cases Referred to Nephrologists for Calcium Disturbance ÇѽÂÇõ(¼¼ºê¶õ½ºº´¿ø)

ÈÞ½Ä 04¿ù 28ÀÏ Room 1 10:30~11:10 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 11:10~11:40 New Trends in the Study of Human Diseases ÀÌÇϸ°(ºÎ»ê´ëÇб³º´¿ø)

½Ä»ç 04¿ù 28ÀÏ Room 1 11:40~14:50 Lunch Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 14:50~15:20 The Clinical Trial Potentials in Asia Pacific Angela Yee-Moon Wang(Queen Mary Hospital, The University of Hong Kong)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 15:20~15:50 What Comes Next after SGLT2 Inhibitors– Emerging CKD Treatments in Clinical Development at Boehringer Ingelheim Motoko Yanagita(Kyoto University Graduate School of Medicine)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 15:50~16:20 Role of Finerenone in CKD Edwina Brown(Imperial College of London)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 16:20~16:50 Targeting Complement in Glomerular Diseases ¿À±¹È¯(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 08:30~09:00 Difference in CRRT Implementation around the World ÀÌÁ¤Ç¥(¼­¿ïƯº°½Ã º¸¶ó¸Åº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 09:00~09:30 Difference in Diagnosis and Management of GN around the World °­¼®ÈÖ(¿µ³²´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 09:30~10:00 Global Nutrition Care in Kidney Disease Benjamin Beno Freedman(University of Washington)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 10:00~10:30 OncoNephrology Update: Clinical Practice Guidelines for the Management of Kidney Injury during Anticancer Drug Therapy 2022 Ryuichi Nishinakamura(Kumamoto University)

ÈÞ½Ä 04¿ù 28ÀÏ Room 3 10:30~10:40 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 10:40~11:10 Glycogen Storage Disease and Kidney Function: Translational Approach ½Å±ÙÀ¯(¼­¿ï´ëÇб³)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 11:10~11:40 Cell Death in Kidney Disease ¹ÚÁöȯ(±¤ÁÖ°úÇбâ¼ú¿ø (GIST))

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 11:40~12:10 Evidence-based Application of Hemodialysis in Acute Kidney Injury ½ÅÀÇö(KAIST (Çѱ¹°úÇбâ¼ú¿ø))

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 12:10~14:40 Vascular Access for Hemodialysis: Clinical Predictors of Recurrent Cephalic Arch Stenosis and Impact of Access Flow Reduction on Patency Rate Francesco Trepiccione(University of Campania)

ÈÞ½Ä 04¿ù 28ÀÏ Room 3 14:40~14:50 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 14:50~15:20 Serum and Urine Biomarker Studies in CKD Andreas Linkermann(Technische Universitat Dresden, Germany)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 15:20~15:50 Urinary Podocyte Markers in Kidney Disease Çѽ¼®(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 15:50~16:20 Omics (GWAS) Research in CKD ±è¿¹´Ï(°¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 16:20~16:50 Integrated Metagenomics and Metabolomics Analysis in CKD ±èÁöÀº(°í·Á´ëÇб³ ±¸·Îº´¿ø)

ÈÞ½Ä 04¿ù 28ÀÏ Room 3 16:50~17:00 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 17:00~17:30 Cardiovascular Risk Factors and CKD Outcomes: Insight from KNOW-CKD Study Àå¹®(¿¹¹Ì´ã¿ä¾çº´¿ø Àΰø½ÅÀå½Ç)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 17:30~18:00 The Chronic Renal Insufficiency Cohort (CRIC) Study – A Landmark Study of Chronic Kidney Disease ¹ÚÁ¤Å¹(¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 18:00~18:30 Clinical Implication of Vascular Calcification in CKD Not Receiving KRT ÀÌÇѺñ(°¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 08:30~09:00 Reappraisal of Peritoneal Dialysis as a Home Treatment Therapy ¼±ÀοÀ(¿¹¼öº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 09:00~09:30 Current Challenges of PD In Korea: Lessions from PDOPPS Korea ¹Ú¿äÇÑ(°Ç¾ç´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 09:30~09:55 The Utility of Remote Patient Monitoring in Patients on PD ÁöÁ¾Çö(°­³²¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 09:55~10:20 Application of Machine Learning for PD Patients ÀüÁؼ®(»ï¼º¼­¿ïº´¿ø)

ÈÞ½Ä 04¿ù 28ÀÏ Room 4 10:20~10:40 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 10:40~10:48 Identification of Regional, Environmental, and Ethnic Factors Related to Renal Function Decline Using the Korean Genome and Epidemiology Study Database ±è¿¹¸²(°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 10:48~10:56 Confirmation of the Electrolyte Concentration in the Dialysate Supplied Through Central Dialysis Fluid Delivery System Á¶¹ÎÇö(°æºÏ´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 10:56~11:04 Novel Non-invasive Chronic Kidney Disease Risk Stratification Tool Derived from Retina-based Deep learning and Clinical Factors for People with Preserved Kidney Function ÃÖ¼ºÀº(CHA ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:04~11:12 Prediction of Intradialytic Hypotension Using Pre-dialysis Features – A Deep Learning Based Artificial Intelligence Model (CMC-IDH-X) ¹Ú¼®¿ì(ºÐ´ç¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:12~11:20 Circulating MicroRNA as a Marker for Scrub Typhus-associated Acute Kidney Injury ¹Ú¼¼ÈÆ(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:20~11:28 Effectiveness of Heart Rate Variability Test in Predicting Intradialytic Hypotension in Chronic Hemodialysis Patients ÀÓÇüÀº(°í·Á´ëÇб³ ¾È»êº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:28~11:36 Erythropoietin Modulates Cell Cycle Arrest to Ameliorate Kidney Fibrosis Á¤¹Î¼±(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:36~11:44 Effects of Angiotensin-converting Enzyme Inhibitors and Agiotensin Receptor Blockers on the Intrarenal Renin-angiotensin System and Ischemic Acute Renal Injury Gabriel Cara-Fuentes(University of Colorado Anschutz Medical Campus)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:44~11:52 Albuminuria and Young Age Onset Diabetes: A Nationwide Population-based Study Akihiro Tojo(Dokkyo Medical University)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:52~12:00 Effect of Donor and Recipient Size Mismatching on the Survival of the Transplanted Kidney in Pediatric Kidney Transplant Patients À¯º´Ã¶(¼øõÇâ´ëÇб³ ºÎ¼Ó ºÎõº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 12:00~12:08 Evaluation of Interobserver Agreement between Renal Pathologists in the Classification of Lupus Nephritis Using Digital Pathology Image Sets Stefano Da Sacco(Keck School of Medicine of University of Southern California)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 12:08~12:16 Efficacy of Mesenchymal Stem Cell (MSC)-derived Extracellular Vesicles (EVs) in Cisplatin Nephrotoxicity Using Three-dimensional Gravity-driven Two-layer Tubule-on-a-chip (3D-MOTIVE chip) Hermann Haller(Hannover University)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 12:16~12:24 Mendelian Randomization Analysis Reveals Causal Factors Related to Kidney Function Muh Geot Wong(The University of Sydney)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 12:24~12:32 Maternal Exposure to Airborne Particulate Matter during Pregnancy and Lactation induces Kidney Injury in Rat Dams and Their Male Offspring: The Role of Vitamin D in Pregnancy and Beyond Dominik Steubl(Boehringer Ingelheim)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 12:32~12:40 Kidney Disease after COVID19 Vaccination in South Korea: Multicenter Study Hermann Haller(Hannover University)

½Ä»ç 04¿ù 28ÀÏ Room 4 12:40~14:50 Lunch Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 14:50~15:20 Donor Specific HLA & Non-HLA Antibodies: Is Progress Being Made Samir Parikh(Ohio State University Wexner Medical Center)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 15:20~15:50 Practical Approach to Individualizing Immunosuppression Strategies According to Alloimmune Risk ¹èÀºÈñ(Àü³²´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 15:50~16:20 Emerging Therapeutic Options for Chronic Active ABMR Cheuk Chun Szeto(The Chinese University of Hong Kong)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 16:20~16:50 From Causes to Care Plan: Non-Immune Mediated Late Graft Failure ¹Ú¼ö°æ(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿¹¹æÀÇÇб³½Ç)

ÈÞ½Ä 04¿ù 28ÀÏ Room 4 16:50~17:00 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 17:00~17:25 Updates on Atypical HUS and C3GN: Prevention and Management Posttransplant I-Wen Wu(Keelung Chang Gung Memorial Hospital)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 17:25~17:50 The Impact of Anti-Viral Therapy and Vaccination on Outcomes In KTRs with Covid-19 ±èÈ¿»ó(¼­¿ï ¾Æ»êº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 17:50~18:15 Are Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors a Game Changer for Improving Posttransplant Outcomes? ¾çÀç¼®(¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 18:15~18:40 New Techniques and Breakthroughs in Noninvasive Allograft Monitoring Hideki Ishida(Tokyo Women)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 08:30~09:00 New Challenges of Kidney Organoids Á¤º´ÇÏ(°¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 09:00~09:30 Generation of 3D Kidneys from Pluripotent Stem Cells ÀÌÁÖÈÆ(¼­¿ï ¾Æ»êº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 09:30~10:00 Creation of Human Assembloids Recapitulating Epithelial-Stomal Interaction in Human Cancer Rukshana Shroff(GOSH)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 10:00~10:30 Single Cell Analysis of Human Organoid Models ½ÅÀçÀÏ(¼¼ºê¶õ½ºº´¿ø)

ÈÞ½Ä 04¿ù 28ÀÏ Room 5 10:30~10:40 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 10:40~11:10 Mechanism of Proteinuria in MCD Including Role of CD80 Yuko Shima(Wakayama Medical University)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 11:10~11:40 Mechanism Underlying Selective Albuminuria in Minimal Change Disease ¼­»óÇå(Àü³²´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 11:40~12:10 Mitochondrial Injury in Pathogenesis of Minimal Change Disease Mahboob Rahman(Case Western Reserve University)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 12:10~14:40 Generation of a Glomerular Filtration Barrier on a Glomerulus-on-a Chip Platform Á¤Âù¿µ(¼­¿ï¾Æ»êº´¿ø)

ÈÞ½Ä 04¿ù 28ÀÏ Room 5 14:40~14:50 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 14:50~15:15 Diet Recommendation for Children with CKD ±è¿ëö(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 15:15~15:40 Nutritional Approach to Deter the Progression of Pediatric CKD ÀÓÁ¤ÈÆ(Ä¥°î°æºÏ´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 15:40~16:05 Immunosuppression to Prevent CKD in Children with IgA Vasculitis °íÀºÁ¤(°¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 16:05~16:30 Management of IgAN and IgAV ÀÌ»óÈ£(°­µ¿°æÈñ´ëÇб³º´¿ø)

ÈÞ½Ä 04¿ù 28ÀÏ Room 5 16:30~17:00 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 17:00~17:25 TIMP-2/IGFBP7 for Predicting AKI Çã¹Ì³ª(°Ç±¹´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 17:25~17:50 Prediction of AKI with a Help of AI ±è±âÇ¥(ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 17:50~18:15 How Close the Exosome therapy is to Us? À¯ÅÂÇö(¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 18:15~18:40 RNAi therapeutics In AKI ±è¼¼Áß(ºÐ´ç¼­¿ï´ëÇб³º´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2023 (2ÀÏÂ÷) : 2023-04-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2023 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2023) (2ÀÏÂ÷) : 2023-04-28
´ÙÀ½±Û 2023 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãá°èÇмú´ëȸ : 2023-04-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20988 ¼­¿ï 2024 Á¦ 13ȸ ´ëÇѺñ´¢»ý½Ä±âÅëÇÕ±â´ÉÀÇÇבּ¸È¸ Çмú´ëȸ : 2024-06-22 0 11 2024-06-14
20987 Ãæ³² 2024³â ´ëÇÑ°í°üÀýÇÐȸ Áø·áÁöħ ½ÉÆ÷Áö¿ò : 2024-06-22 0 10 2024-06-14
20986 ±¤ÁÖ Á¦24ȸ ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ È£³²Áöȸ Á¤±âÇмú´ëȸ : 2024-06-22 0 15 2024-06-14
20985 °æ±â ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Annual Academy for young oncologists(2ÀÏÂ÷) : 2024-06-22 0 9 2024-06-14
20984 °æºÏ ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦43Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-22 0 8 2024-06-14
20983 °æ³² 2024 ÁøÁÖ½ÃÀÇ»çȸ »ó¹Ý±â Àǻ翬¼ö±³À° : 2024-06-22 0 4 2024-06-14
20982 °æ±â °¡Å縯´ëÇб³ÀÇÁ¤ºÎ¼º¸ðº´¿ø Á¦ 8Â÷ °æ±âºÏºÎ °³¿øÀǸ¦ À§ÇÑ Çмú´ëȸ : 2024-06-22 0 5 2024-06-14
20981 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-22 0 7 2024-06-14
20980 ¼­¿ï ´ëÇÑÈĵÎÀ½¼º¾ð¾îÀÇÇÐȸ 11ȸ °ø¿¬¹ß¼º ½ÉÆ÷Áö¾ö : 2024-06-22 0 5 2024-06-14
20979 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ ³ëÀÎÀçÈ°Àü¹®°¡ ½ÉÈ­°úÁ¤ : 2024-06-22 0 5 2024-06-14
20978 ÀüºÏ Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22 0 5 2024-06-14
20977 Á¦ÁÖ ´ëÇѳúÇ÷°ü³»Ä¡·áÀÇÇÐȸ The 18th Annual Summer Conference on Endovascular Neurosurgical Therapy (ASCENT 2024) 2ÀÏÂ÷ : 2024-06-22 0 4 2024-06-14
20976 ±¤ÁÖ 2024³â »ó¹Ý±â ±¤ÁÖ±¤¿ª½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-22 0 12 2024-06-14
20975 ¼­¿ï 2024³â ´ëÇÑÀÇ·áÁ¤º¸ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-21 0 4 2024-06-14
20974 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2024 SNUH Rare Disease Workshop : 2024-06-21 0 3 2024-06-14
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷